Enhance MD vs Gala: Which flat-rate GLP-1 plan fits you?
Enhance MD vs Gala quickly: Enhance MD emphasizes very low introductory pricing and flat-rate dosing, while Gala promotes a flat all-inclusive plan with provider check-ins and a $220 promotion. Early verdict: for the lowest first-month entry cost choose Enhance MD; for included provider visit, shipping and a single bundled price consider Gala.
See Enhance MD starting options
Head-to-head summary: Pricing and what is shown up front
Both platforms sell compounded GLP-1s and state treatment is subject to clinician review. Enhance MD lists semaglutide from $49 and tirzepatide from $99 for the first month and emphasizes flat-rate pricing that stays the same at every dose. Gala advertises one flat all-inclusive price covering provider visit, medication, shipping and ongoing care and a $220 promotion, but the base dollar price was not exposed in readable page text.
Distinctive difference 1: First-month entry cost
Enhance MD supplies explicit first-month starting prices: semaglutide from $49 and tirzepatide from $99. Gala does not expose a clear base price in the captured text and instead highlights a $220 discount and a flat all-inclusive offering. If first-month sticker price is decisive, Enhance MD provides the clearest low-cost figures.
Check Gala enrollment and promotion
Distinctive difference 2: What the flat price covers
Enhance MD describes flat-rate pricing that stays the same at every dose and warns ongoing flat-rate pricing may be higher after introductory month. Gala claims one flat price at every dose and advertises that the flat all-inclusive price covers the provider visit, prescription, medication, shipping and ongoing care. Gala also emphasizes provider check-ins and home delivery in the captured evidence.
Distinctive difference 3: Service features and logistics
Gala explicitly lists provider visit and prescription included, provider check-ins, and free two-day shipping. Enhance MD highlights clinician-directed care, a platform offering both semaglutide and tirzepatide, and a stated clinical volume of more than 10,000 patients treated. Both operate on a direct-pay model in the captured evidence and both offer compounded medications.
Comparison table
| Criteria | Enhance MD | Gala |
|---|---|---|
| First-month pricing shown | Semaglutide from $49; Tirzepatide from $99 (first month) | Page advertises a $220 promotion; base price not exposed in readable page text |
| Flat-rate dose pricing | Flat-rate pricing: same price at every dose; ongoing rate may be higher after intro | Claims one flat price at every dose; described as all-inclusive in captured text |
| Compounds offered | Compounded semaglutide and tirzepatide | Compounded semaglutide and tirzepatide |
| Included clinical services | Clinician-directed review; treated 10,000+ patients | Provider visit and prescription included; provider check-ins included |
| Shipping and delivery | Not specified in captured Enhance MD text | Free two-day shipping stated |
| Regulatory note | Compounded medications are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality | Compounded medications are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality |
View Enhance MD program details
Clinical review, transparency and limits
Enhance MD describes clinician-directed compounds and notes treatment is available only when a licensed clinician determines it is medically appropriate. Enhance MD also states compounded medications, when offered, are not FDA-approved and are not reviewed by the FDA for safety, effectiveness or quality. Gala includes the same regulatory note in the captured evidence and reinforces that treatment is clinician-directed; Gala additionally shows testimonials and weight-loss examples in the captured landing copy but those are provider marketing in the captured evidence.
Final comparison and recommendation
Enhance MD vs Gala centers on two main tradeoffs in the captured evidence: explicit low first-month prices and a published flat-rate approach at Enhance MD versus Gala’s bundled all-inclusive plan with provider visit, check-ins and free two-day shipping but no clear base price shown in the readable capture. Both offer compounded semaglutide and tirzepatide and both state clinician review is required. Both note that compounded medications are not FDA-approved.
Choose Enhance MD if…
you prioritize the lowest clearly advertised first-month entry cost and want both semaglutide and tirzepatide options with flat-rate dose pricing and a provider platform that reports treating 10,000+ patients.
Choose Gala if…
you prefer a bundled, all-inclusive plan that explicitly includes the provider visit and prescription, provider check-ins and free two-day shipping and you will confirm the final base price and renewal terms before enrolling.